Blueprint: New Pharmaceutical & Nutraceutical Product Line

This document outlines the strategic formulation, manufacturing specifications, and compliance parameters required to launch a new product line across three core pharmaceutical segments.

1. 💊 New Capsule Range: Multivitamin & Antioxidant Softgels

Therapeutic Intent: Daily immunity, cellular health, and vitality booster for general wellness markets.
The Formulation: A synergistic blend of Omega-3 fatty acids (EPA/DHA), Green Tea Extract, Ginseng Extract, Lycopene, Coenzyme Q10, Zinc Oxide, and essential Vitamins (D3, B12).
Manufacturing Specifications: Soft gelatin encapsulation utilizing an oil-based suspension vehicle to maximize https://www.wingsbiotechlifecare.com/ the bioavailability of fat-soluble ingredients. The outer gelatin shell is treated with an opaque, light-resistant colorant to prevent UV-induced ingredient degradation.
Commercial Packaging: Alulalu or blister strips of 10 or 15 capsules, housed in a matte-finish outer carton featuring a premium brand aesthetic.

2. 🧪 New Dry Syrup Range: Pediatric Cefixime Oral Suspension

Therapeutic Intent: Broad-spectrum pediatric antibiotic targeting acute respiratory, ear, and urinary tract infections.
The Formulation: Cefixime Trihydrate Active Pharmaceutical Ingredient (API) blended with sweetening agents (sucralose), dry flavor enhancers (mixed fruit/strawberry), xanthan gum (suspending agent), and colloidal silicon dioxide (glidant).
Manufacturing Specifications: Processed under strict class-100,000 humidity-controlled environments. The formulation requires dry granulation to ensure uniform particle distribution and prevent moisture-induced caking prior to reconstitution.
Commercial Packaging: 30ml high-density polyethylene (HDPE) amber bottles paired with a calibrated 5ml oral dosing cup and a separate sterile water sachet for precise home reconstitution.

3. 🥤 New Protein Powder Range: Diabetic Care Nutrition Blend

Therapeutic Intent: Low-glycemic, high-protein clinical supplement designed for blood sugar management, weight control, and lean muscle retention.
The Formulation: A clean protein matrix of Whey Protein Isolate and Micellar Casein, fortified with Dietary Fiber (Inulin), Chromium Picolinate, Alpha-Lipoic Acid, and a sugar-free sweetener blend (Stevia/Sucralose).
Manufacturing Specifications: Uniform mechanical ribbon blending ensures an equal distribution of micronutrients throughout the dense protein base, preventing ingredient stratification or separation during transit.
Commercial Packaging: 400g air-tight composite tin cans or vacuum-sealed standing zipper pouches, containing an internal 30g measuring scoop.

📋 Commercial Launch Checklist

To transition these technical concepts into an active commercial production run, ensure the following parameters are established with your third-party contract manufacturing partner:

Minimum Order Quantities (MOQs)

Capsule Line: 100,000 to 150,000 capsules per batch.
Dry Syrup Line: 5,000 to 10,000 bottles per run.
Protein Powder: 2,000 to 3,000 jars/pouches per SKU.

Quality Control & Compliance

Licensing: Formulations must comply with regional food safety authorities (e.g., FSSAI for protein powders) and drug controllers (e.g., DCGI/FDA for antibiotic syrups).

Testing: Every commercial batch requires real-time and accelerated stability testing, heavy metal profiling, and microbial load verification before market release.